White Diamond has been “reporting” on TRXC since fda. I’m invested in both. They seem to publish these after any sign of good news. The first one or two drove it down to $1.30. FYI, in my short experience, wait 2-3 months, then buy. Their articles can be very lucrative if you’re patient!! Short term, white diamond is reaching ( for their own agenda). Look at TRXC now.
As for Titan, we’re a year away from anything that can be remotely positive as far as PPS. Using TRXC as an example, there is interest in this market. Titan, in my eyes, has much more potential. Plenty of DD needed, and plenty of balls needed to jump in.
Regardless, it’s been said (don’t quote me, I saw on this board) that they were looking at 8-10 years from idea to commercialization (and I believe in the product too much to actually research that comment). Pretty close to that year mark now. Would u like TRXC at $2 or $7? I’m in at $1.50 and riding. As risky as both are, Titan could be right behind
News 
Market Data 
Discover 
AI
